The CeramTec Group has taken the next step in the transformation into a medical technology corporation and acquired the Swiss specialist for ceramic dental implants, Dentalpoint AG. With this acquisition, the globally leading medical technology group further expands its offering as a supplier in the field of high-performance ceramics. The CeramTec Group's high-quality, biocompatible ceramic components for joint and dental implants help patients worldwide to improve their lives.
With the acquisition of the Swiss company Dentalpoint AG ("Dentalpoint") on 4 January 2021, CeramTec is investing in the rapidly growing future market for metal-free dental prostheses and is sustainably expanding its portfolio for medical technology applications. As one of the leading suppliers in the field of metal-free, two-piece ceramic implants, Dentalpoint makes a substantial contribution to the development of implantology and has an established and innovative product platform. The transaction will create a leading global provider of solutions in the field of ceramic dental implants, which combine the highest product quality in terms of biocompatibility and aesthetics.
"With this acquisition, we not only consistently expand our portfolio in the Medical segment, but at the same time we are expanding our access to the dental market, our product development expertise and our manufacturing capacities in a strongly growing market environment," says Dr. Hadi Saleh, CEO of the CeramTec Group.
Adrian Hunn, CEO of Dentalpoint AG, adds: "Through the integration into the CeramTec Group, we expect new impulses for our existing business and the expansion of our international presence. At the same time, Dentalpoint will remain a stand-alone company with the established Zeramex brand and will continue to expand."
Dentalpoint has state-of-the-art production technology and automated manufacturing processes. For more than 10 years, customers have trusted the high-quality and customized product solutions from Switzerland.
CeramTec has over 45 years of experience with high-performance ceramics for medical technology applications, which are successfully used worldwide for the benefit of patients. CeramTec's ceramic implants are metal-free and have excellent bio-compatibility, chemical stability and high wear resistance. The company's proven expertise in materials and injection molding in particular enables the cost-efficient production of dental implants.
Ceramtec was supported by Homburger AG in Zurich as to legal matters and by Morgan Stanley as financial advisor.
